What is a common treatment option for SLE?

Corticosteroids are a common treatment option for SLE (Systemic Lupus Erythematosus). These medications are prescribed to reduce inflammation and suppress the overactive immune response that characterizes the disease. Corticosteroids can quickly alleviate symptoms during flares and help manage complications, making them a vital part of SLE management.

While nonsteroidal anti-inflammatory drugs (NSAIDs) are used to manage mild to moderate pain and inflammation associated with SLE, they do not address the underlying immune dysfunction of the disease. Thus, corticosteroids are often favored for their ability to more effectively control SLE symptoms and maintain disease remission.

Antibiotics are not typically part of SLE management, as they are used to treat bacterial infections rather than autoimmune diseases. Insulin therapy is specifically aimed at managing diabetes and would not be relevant in treating SLE. Therefore, while NSAIDs can play a role in symptomatic relief, corticosteroids remain a cornerstone treatment due to their broader effectiveness in controlling the disease.